Dr. Schneider is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1520 San Pablo St
Ste 1652
Los Angeles, CA 90033Phone+1 323-442-6000Fax+1 323-442-6001
Education & Training
- University of Southern California School of MedicineMS, Applied Biometry and Epidemiology, 1995
- University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Psychiatry, 1978 - 1983
- Drexel University College of MedicineClass of 1978
Certifications & Licensure
- CA State Medical License 1979 - 2025
- American Board of Psychiatry and Neurology Psychiatry
- American Board of Psychiatry and Neurology Geriatric Psychiatry
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- CATIE-Alzheimer's Disease Trial Start of enrollment: 2001 Mar 01
- Citalopram for Agitation in Alzheimer's Disease Start of enrollment: 2009 Jul 01
- Phytoserms for Menopause Symptoms and Age-Associated Memory Decline Start of enrollment: 2012 Jul 01
- Join now to see all
Publications & Presentations
PubMed
- 20 citationsThe small HDL particle hypothesis of Alzheimer's disease.Ashley E Martinez, Gali Weissberger, Zsuzsanna Kuklenyik, Xulei He, Cristiana Meuret
Alzheimer's & Dementia. 2023-02-01 - 175 citationsCaregiver Burden in Alzheimer Disease: Cross-Sectional and Longitudinal Patient CorrelatesSomaia Mohamed, Robert A. Rosenheck, Constantine G. Lyketsos, Lon S. Schneider
The American Journal of Geriatric Psychiatry. 2010-10-01 - 19 citationsMaking the Case for Accelerated Withdrawal of Aducanumab.Peter Whitehouse, Sam Gandy, Vikas Saini, Daniel R George, Eric B Larson
Journal of Alzheimer's Disease. 2022-01-01
Press Mentions
- If Alzheimer's Drug Ads Had More Data, Here's What Might HappenAugust 30th, 2024
- Challenges of Anti-Amyloid Therapies in Alzheimer’s Disease: Neurologists’ PerspectivesJuly 30th, 2024
- Survey: Neurologists Split on Prescribing New Alzheimer’s TreatmentsJuly 28th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: